The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Retinal Disorders Treatment Market Research Report 2024
Synopsis
Technological advancements are set to play a key role in the overall growth of the global retinal disorders treatment market in the upcoming years. Groundbreaking breakthroughs and advancements in bionics, genetics, and stem-cell therapy are expected to transform the future of retinal disorders treatment in the upcoming decade. In developed regions wherein the preventable causes of blindness are detected early, owing to routine checkups and robust healthcare ecosystem, retinal degeneration has emerged as one of the top causes of blindness or visual impairment. Macular degeneration is of two types: wet age-related macular degeneration and dry age-related macular degeneration. Diabetic retinopathy is one of the common diabetic eye disorders characterized by damaged blood vessels in the retina. The damaged blood vessels and nerves lead to vision impairment, blurring of vision, and eye hemorrhage. If left untreated, it could lead to retinal detachment and blindness.
The global Retinal Disorders Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Retinal Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorders Treatment.
Report Scope
The Retinal Disorders Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retinal Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retinal Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan plc
Bayer AG, F.
Hoffmann-La Roche Ltd.
Graybug Vision, Inc.
Kubota Pharmaceutical Holdings Co., Ltd.
Novartis AG
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Pfizer
Segment by Type
Gels
Ointments
Capsules & Tablets
Eye Drops
Segment by Application
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retinal Disorders Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Technological advancements are set to play a key role in the overall growth of the global retinal disorders treatment market in the upcoming years. Groundbreaking breakthroughs and advancements in bionics, genetics, and stem-cell therapy are expected to transform the future of retinal disorders treatment in the upcoming decade. In developed regions wherein the preventable causes of blindness are detected early, owing to routine checkups and robust healthcare ecosystem, retinal degeneration has emerged as one of the top causes of blindness or visual impairment. Macular degeneration is of two types: wet age-related macular degeneration and dry age-related macular degeneration. Diabetic retinopathy is one of the common diabetic eye disorders characterized by damaged blood vessels in the retina. The damaged blood vessels and nerves lead to vision impairment, blurring of vision, and eye hemorrhage. If left untreated, it could lead to retinal detachment and blindness.
The global Retinal Disorders Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Retinal Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorders Treatment.
Report Scope
The Retinal Disorders Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retinal Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retinal Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan plc
Bayer AG, F.
Hoffmann-La Roche Ltd.
Graybug Vision, Inc.
Kubota Pharmaceutical Holdings Co., Ltd.
Novartis AG
Regeneron Pharmaceuticals, Inc.
Santen Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Pfizer
Segment by Type
Gels
Ointments
Capsules & Tablets
Eye Drops
Segment by Application
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retinal Disorders Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorders Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gels
1.2.3 Ointments
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.3 Market by Application
1.3.1 Global Retinal Disorders Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Macular Degeneration
1.3.3 Diabetic Retinopathy
1.3.4 Diabetic Macular Edema
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorders Treatment Market Perspective (2019-2030)
2.2 Retinal Disorders Treatment Growth Trends by Region
2.2.1 Global Retinal Disorders Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Retinal Disorders Treatment Historic Market Size by Region (2019-2024)
2.2.3 Retinal Disorders Treatment Forecasted Market Size by Region (2025-2030)
2.3 Retinal Disorders Treatment Market Dynamics
2.3.1 Retinal Disorders Treatment Industry Trends
2.3.2 Retinal Disorders Treatment Market Drivers
2.3.3 Retinal Disorders Treatment Market Challenges
2.3.4 Retinal Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorders Treatment Players by Revenue
3.1.1 Global Top Retinal Disorders Treatment Players by Revenue (2019-2024)
3.1.2 Global Retinal Disorders Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Retinal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorders Treatment Revenue
3.4 Global Retinal Disorders Treatment Market Concentration Ratio
3.4.1 Global Retinal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Treatment Revenue in 2023
3.5 Retinal Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Retinal Disorders Treatment Product Solution and Service
3.7 Date of Enter into Retinal Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorders Treatment Breakdown Data by Type
4.1 Global Retinal Disorders Treatment Historic Market Size by Type (2019-2024)
4.2 Global Retinal Disorders Treatment Forecasted Market Size by Type (2025-2030)
5 Retinal Disorders Treatment Breakdown Data by Application
5.1 Global Retinal Disorders Treatment Historic Market Size by Application (2019-2024)
5.2 Global Retinal Disorders Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Retinal Disorders Treatment Market Size (2019-2030)
6.2 North America Retinal Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Retinal Disorders Treatment Market Size by Country (2019-2024)
6.4 North America Retinal Disorders Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retinal Disorders Treatment Market Size (2019-2030)
7.2 Europe Retinal Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Retinal Disorders Treatment Market Size by Country (2019-2024)
7.4 Europe Retinal Disorders Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorders Treatment Market Size (2019-2030)
8.2 Asia-Pacific Retinal Disorders Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Retinal Disorders Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Retinal Disorders Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retinal Disorders Treatment Market Size (2019-2030)
9.2 Latin America Retinal Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Retinal Disorders Treatment Market Size by Country (2019-2024)
9.4 Latin America Retinal Disorders Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorders Treatment Market Size (2019-2030)
10.2 Middle East & Africa Retinal Disorders Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Retinal Disorders Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Retinal Disorders Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Detail
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Retinal Disorders Treatment Introduction
11.1.4 Allergan plc Revenue in Retinal Disorders Treatment Business (2019-2024)
11.1.5 Allergan plc Recent Development
11.2 Bayer AG, F.
11.2.1 Bayer AG, F. Company Detail
11.2.2 Bayer AG, F. Business Overview
11.2.3 Bayer AG, F. Retinal Disorders Treatment Introduction
11.2.4 Bayer AG, F. Revenue in Retinal Disorders Treatment Business (2019-2024)
11.2.5 Bayer AG, F. Recent Development
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Detail
11.3.2 Hoffmann-La Roche Ltd. Business Overview
11.3.3 Hoffmann-La Roche Ltd. Retinal Disorders Treatment Introduction
11.3.4 Hoffmann-La Roche Ltd. Revenue in Retinal Disorders Treatment Business (2019-2024)
11.3.5 Hoffmann-La Roche Ltd. Recent Development
11.4 Graybug Vision, Inc.
11.4.1 Graybug Vision, Inc. Company Detail
11.4.2 Graybug Vision, Inc. Business Overview
11.4.3 Graybug Vision, Inc. Retinal Disorders Treatment Introduction
11.4.4 Graybug Vision, Inc. Revenue in Retinal Disorders Treatment Business (2019-2024)
11.4.5 Graybug Vision, Inc. Recent Development
11.5 Kubota Pharmaceutical Holdings Co., Ltd.
11.5.1 Kubota Pharmaceutical Holdings Co., Ltd. Company Detail
11.5.2 Kubota Pharmaceutical Holdings Co., Ltd. Business Overview
11.5.3 Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Introduction
11.5.4 Kubota Pharmaceutical Holdings Co., Ltd. Revenue in Retinal Disorders Treatment Business (2019-2024)
11.5.5 Kubota Pharmaceutical Holdings Co., Ltd. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Retinal Disorders Treatment Introduction
11.6.4 Novartis AG Revenue in Retinal Disorders Treatment Business (2019-2024)
11.6.5 Novartis AG Recent Development
11.7 Regeneron Pharmaceuticals, Inc.
11.7.1 Regeneron Pharmaceuticals, Inc. Company Detail
11.7.2 Regeneron Pharmaceuticals, Inc. Business Overview
11.7.3 Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Introduction
11.7.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Disorders Treatment Business (2019-2024)
11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
11.8 Santen Pharmaceutical Co., Ltd.
11.8.1 Santen Pharmaceutical Co., Ltd. Company Detail
11.8.2 Santen Pharmaceutical Co., Ltd. Business Overview
11.8.3 Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Introduction
11.8.4 Santen Pharmaceutical Co., Ltd. Revenue in Retinal Disorders Treatment Business (2019-2024)
11.8.5 Santen Pharmaceutical Co., Ltd. Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Detail
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Retinal Disorders Treatment Business (2019-2024)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Retinal Disorders Treatment Introduction
11.10.4 Pfizer Revenue in Retinal Disorders Treatment Business (2019-2024)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Retinal Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gels
Table 3. Key Players of Ointments
Table 4. Key Players of Capsules & Tablets
Table 5. Key Players of Eye Drops
Table 6. Global Retinal Disorders Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Retinal Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Retinal Disorders Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Retinal Disorders Treatment Market Share by Region (2019-2024)
Table 10. Global Retinal Disorders Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Retinal Disorders Treatment Market Share by Region (2025-2030)
Table 12. Retinal Disorders Treatment Market Trends
Table 13. Retinal Disorders Treatment Market Drivers
Table 14. Retinal Disorders Treatment Market Challenges
Table 15. Retinal Disorders Treatment Market Restraints
Table 16. Global Retinal Disorders Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Retinal Disorders Treatment Market Share by Players (2019-2024)
Table 18. Global Top Retinal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Treatment as of 2023)
Table 19. Ranking of Global Top Retinal Disorders Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Retinal Disorders Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disorders Treatment Product Solution and Service
Table 23. Date of Enter into Retinal Disorders Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorders Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Retinal Disorders Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Retinal Disorders Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Retinal Disorders Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Retinal Disorders Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Retinal Disorders Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Retinal Disorders Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Retinal Disorders Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Retinal Disorders Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Retinal Disorders Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Retinal Disorders Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Retinal Disorders Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Retinal Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Retinal Disorders Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Retinal Disorders Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Retinal Disorders Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Retinal Disorders Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Retinal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Retinal Disorders Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Retinal Disorders Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Allergan plc Company Detail
Table 49. Allergan plc Business Overview
Table 50. Allergan plc Retinal Disorders Treatment Product
Table 51. Allergan plc Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 52. Allergan plc Recent Development
Table 53. Bayer AG, F. Company Detail
Table 54. Bayer AG, F. Business Overview
Table 55. Bayer AG, F. Retinal Disorders Treatment Product
Table 56. Bayer AG, F. Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 57. Bayer AG, F. Recent Development
Table 58. Hoffmann-La Roche Ltd. Company Detail
Table 59. Hoffmann-La Roche Ltd. Business Overview
Table 60. Hoffmann-La Roche Ltd. Retinal Disorders Treatment Product
Table 61. Hoffmann-La Roche Ltd. Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 62. Hoffmann-La Roche Ltd. Recent Development
Table 63. Graybug Vision, Inc. Company Detail
Table 64. Graybug Vision, Inc. Business Overview
Table 65. Graybug Vision, Inc. Retinal Disorders Treatment Product
Table 66. Graybug Vision, Inc. Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 67. Graybug Vision, Inc. Recent Development
Table 68. Kubota Pharmaceutical Holdings Co., Ltd. Company Detail
Table 69. Kubota Pharmaceutical Holdings Co., Ltd. Business Overview
Table 70. Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Product
Table 71. Kubota Pharmaceutical Holdings Co., Ltd. Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 72. Kubota Pharmaceutical Holdings Co., Ltd. Recent Development
Table 73. Novartis AG Company Detail
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Retinal Disorders Treatment Product
Table 76. Novartis AG Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 77. Novartis AG Recent Development
Table 78. Regeneron Pharmaceuticals, Inc. Company Detail
Table 79. Regeneron Pharmaceuticals, Inc. Business Overview
Table 80. Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Product
Table 81. Regeneron Pharmaceuticals, Inc. Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 82. Regeneron Pharmaceuticals, Inc. Recent Development
Table 83. Santen Pharmaceutical Co., Ltd. Company Detail
Table 84. Santen Pharmaceutical Co., Ltd. Business Overview
Table 85. Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Product
Table 86. Santen Pharmaceutical Co., Ltd. Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 87. Santen Pharmaceutical Co., Ltd. Recent Development
Table 88. Takeda Pharmaceutical Company Limited Company Detail
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Product
Table 91. Takeda Pharmaceutical Company Limited Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 92. Takeda Pharmaceutical Company Limited Recent Development
Table 93. Pfizer Company Detail
Table 94. Pfizer Business Overview
Table 95. Pfizer Retinal Disorders Treatment Product
Table 96. Pfizer Revenue in Retinal Disorders Treatment Business (2019-2024) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorders Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Retinal Disorders Treatment Market Share by Type: 2023 VS 2030
Figure 3. Gels Features
Figure 4. Ointments Features
Figure 5. Capsules & Tablets Features
Figure 6. Eye Drops Features
Figure 7. Global Retinal Disorders Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Retinal Disorders Treatment Market Share by Application: 2023 VS 2030
Figure 9. Macular Degeneration Case Studies
Figure 10. Diabetic Retinopathy Case Studies
Figure 11. Diabetic Macular Edema Case Studies
Figure 12. Others Case Studies
Figure 13. Retinal Disorders Treatment Report Years Considered
Figure 14. Global Retinal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Retinal Disorders Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Retinal Disorders Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Retinal Disorders Treatment Market Share by Players in 2023
Figure 18. Global Top Retinal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Retinal Disorders Treatment Revenue in 2023
Figure 20. North America Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Retinal Disorders Treatment Market Share by Country (2019-2030)
Figure 22. United States Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Retinal Disorders Treatment Market Share by Country (2019-2030)
Figure 26. Germany Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Retinal Disorders Treatment Market Share by Region (2019-2030)
Figure 34. China Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Retinal Disorders Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Retinal Disorders Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Retinal Disorders Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Allergan plc Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 49. Bayer AG, F. Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 50. Hoffmann-La Roche Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 51. Graybug Vision, Inc. Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 52. Kubota Pharmaceutical Holdings Co., Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 53. Novartis AG Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 54. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 55. Santen Pharmaceutical Co., Ltd. Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 56. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Retinal Disorders Treatment Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
